Breaking News Instant updates and real-time market news.

SNY

Sanofi

$42.11

0.56 (1.35%)

, BIVV

Bioverativ

$103.24

-0.26 (-0.25%)

06:39
02/07/18
02/07
06:39
02/07/18
06:39

Sanofi reports Q4 business EPS EUR1.06, down 8.7% at CER

Net sales were EUR8.691B, down 2.0% on a reported basis and up 4.1% at CER. At CER/CS, net sales were down 1.6%. Sanofi (SNY) CEO, Olivier Brandicourt, commented: "In 2017, we continued to execute on our strategic goals with the strong launch of Dupixent, the positive pivotal data for cemiplimaband for dupilumab in asthma. At the same time, we managed the challenges in U.S. diabetes as well as the impact from sevelamergenerics and Dengvaxia. Recently, we announced a series of strategic steps -- we are obtaining the global rights to fitusiran and plan to acquire Bioverativ (BIVV) and Ablynx (ABLX) -- which will establish Sanofi as a new global leader in rare blood disorders. Additionally, these actions will further strengthen our pipeline and provide us with the powerful new Nanobody technology platform. Overall, after a period of significant reshaping since 2015, we are positioned to drive growth in 2018.

SNY

Sanofi

$42.11

0.56 (1.35%)

BIVV

Bioverativ

$103.24

-0.26 (-0.25%)

ABLX

Ablynx

$54.02

-0.08 (-0.15%)

  • 07

    Feb

  • 12

    Feb

  • 14

    Feb

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 02

    May

SNY Sanofi
$42.11

0.56 (1.35%)

01/22/18
JEFF
01/22/18
DOWNGRADE
Target $105
JEFF
Hold
Bioverativ downgraded to Hold from Buy at Jefferies
Jefferies analyst Eun Yang downgraded Bioverativ (BIVV) while raising her price target for the shares to $105 from $79 following the takeover by Sanofi (SNY). The analyst views the potential for a counterbid as unlikely given the "quite healthy" deal premium and potential synergy with Sanofi pipeline.
01/23/18
LEHM
01/23/18
DOWNGRADE
LEHM
Underweight
Sanofi downgraded to Underweight from Equal Weight at Barclays
01/24/18
FBCO
01/24/18
NO CHANGE
Target $105
FBCO
Neutral
Bioverativ price target raised to $105 from $65 at Credit Suisse
Credit Suisse analyst Martin Auster raised his price target for Bioverativ (BIVV) to $105 from $65 ahead of likely closing of the Sanofi (SNY) deal. The analyst reiterates a Neutral rating on Bioverativ's shares.
01/24/18
ARGS
01/24/18
DOWNGRADE
ARGS
Hold
Bioverativ downgraded to Hold from Buy at Argus
Argus analyst Jasper Hellweg downgraded Bioverativ (BIVV) to Hold from Buy after the company announced a deal to be acquired by Sanofi (SNY) for $105 per share in cash. Hellweg says the strong run-up in the stock and the forthcoming acquisition have fully valued the stock at current levels.
BIVV Bioverativ
$103.24

-0.26 (-0.25%)

01/23/18
MSCO
01/23/18
UPGRADE
Target $105
MSCO
Equal Weight
Bioverativ upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison upgraded Bioverativ (BIVV) to Equal Weight after the company announced a deal to be acquired by Sanofi (SNY) for $105 per share in cash.
ABLX Ablynx
$54.02

-0.08 (-0.15%)

11/20/17
11/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Innoviva (INVA) initiated with a Hold at Deutsche Bank. 2. National Vision (EYE) was initiated with an Overweight at Morgan Stanley, an Outperform at Wells Fargo, a Buy at Jefferies and Citi, as well as a Neutral at Goldman Sachs, UBS, and BofA/Merrill. 3. Ablynx (ABLX) was initiated with an Overweight at JPMorgan, an Outperform at Baird, and a Buy at Ladenburg. 4. Blue Apron (APRN) initiated with a Sector Weight at KeyBanc. 5. BP Midstream (BPMP) was initiated with an Overweight at JPMorgan, a Buy at UBS and Citi, an Equal Weight at Morgan Stanley and Barclays, as well as a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/08/18
DBAB
01/08/18
NO CHANGE
DBAB
Buy
Novo offer for Ablynx makes strategic sense, says Deutsche Bank
Deutsche Bank analyst Tim Race views Novo Nordisk's (NVO) acquisition offer for Ablynx (ABLX) as sensible, fitting with the stated company strategy and at a reasonable price. Depending on how discussions develop, the analyst would expect Novo to potentially raise its offer. Ablynx's caplacizumab could leverage Novo's readymade global haematology sales force with minimal additional cost, Race tells investors in a research note. The analyst keeps a Buy rating on Novo Nordisk.
01/09/18
BARD
01/09/18
NO CHANGE
Target $33
BARD
Outperform
Ablynx bid a floor for shares, other bids could follow, says Baird
Baird analyst Brian Skorney noted Novo Nordisk (NVO) went public with its $3.1B bid for Ablynx (ABLX). He believes the shares will trade above that level and that a new bid will emerge, although there are no other bidders yet. Skorney reiterated his Outperform rating and $33 price target on Ablynx shares.
01/29/18
BARD
01/29/18
DOWNGRADE
Target $56
BARD
Neutral
Ablynx downgraded to Neutral from Outperform at Baird
Sanofi (SNY) and Ablynx (ABLX) entered into a definitive agreement under which Sanofi will offer to acquire Ablynx.

TODAY'S FREE FLY STORIES

TFX

Teleflex

$280.29

-1.61 (-0.57%)

15:20
06/18/18
06/18
15:20
06/18/18
15:20
Conference/Events
Teleflex management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 21

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

  • 05

    Sep

GME

GameStop

$14.27

0.355 (2.55%)

15:19
06/18/18
06/18
15:19
06/18/18
15:19
Periodicals
GameStop talks with PE firms after seeing takeover interest, Reuters says »

GameStop is holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

OFC

Corporate Office Properties

$27.36

-0.055 (-0.20%)

15:18
06/18/18
06/18
15:18
06/18/18
15:18
Conference/Events
Corporate Office Properties management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/18/18
06/18
15:17
06/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/18/18
06/18
15:16
06/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$14.27

0.355 (2.55%)

15:11
06/18/18
06/18
15:11
06/18/18
15:11
Hot Stocks
Breaking Hot Stocks news story on GameStop 

GameStop trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

HDP

Hortonworks

$19.96

0.86 (4.50%)

15:10
06/18/18
06/18
15:10
06/18/18
15:10
Options
Higher call activity in HortonNetworks as shares see relative strength »

Higher call activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
06/18/18
06/18
15:10
06/18/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

GME

GameStop

$14.29

0.375 (2.69%)

15:08
06/18/18
06/18
15:08
06/18/18
15:08
Hot Stocks
GameStop jumps after Reuters reports on takeover interest »

Shares of GameStop (GME)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

QTNT

Quotient

$8.33

1.2 (16.83%)

15:08
06/18/18
06/18
15:08
06/18/18
15:08
Conference/Events
Quotient management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GME

GameStop

$14.30

0.385 (2.77%)

15:06
06/18/18
06/18
15:06
06/18/18
15:06
Periodicals
Breaking Periodicals news story on GameStop »

GameStop talks with PE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

GME

GameStop

$14.31

0.395 (2.84%)

15:05
06/18/18
06/18
15:05
06/18/18
15:05
Hot Stocks
Breaking Hot Stocks news story on GameStop »

GameStop trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

SKX

Skechers

$29.23

-0.2 (-0.68%)

15:05
06/18/18
06/18
15:05
06/18/18
15:05
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CME

CME Group

$169.09

-0.7 (-0.41%)

14:55
06/18/18
06/18
14:55
06/18/18
14:55
Conference/Events
CME Group management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

  • 26

    Jul

BIG

Big Lots

$41.35

0.11 (0.27%)

14:55
06/18/18
06/18
14:55
06/18/18
14:55
Options
Big Lots put volume heavy and directionally bearish »

Bearish flow noted in Big…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJW

SJW Corp.

$66.69

-0.16 (-0.24%)

, CTWS

Connecticut Water

$65.50

0.5 (0.77%)

14:49
06/18/18
06/18
14:49
06/18/18
14:49
Hot Stocks
SJW sees giving shareholders chance to vote on Connecticut Water deal ASAP »

SJW Group (SJW) commented…

SJW

SJW Corp.

$66.69

-0.16 (-0.24%)

CTWS

Connecticut Water

$65.50

0.5 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$98.07

3.2 (3.37%)

14:45
06/18/18
06/18
14:45
06/18/18
14:45
Recommendations
PTC analyst commentary  »

PTC price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

OXY

Occidental Petroleum

$84.23

0.9 (1.08%)

14:45
06/18/18
06/18
14:45
06/18/18
14:45
Options
Occidental Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$43.86

1.33 (3.13%)

14:41
06/18/18
06/18
14:41
06/18/18
14:41
Recommendations
Etsy analyst commentary  »

Etsy price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

BUD

AB InBev

$96.45

-2.05 (-2.08%)

14:37
06/18/18
06/18
14:37
06/18/18
14:37
Hot Stocks
AB InBev, Kiip launch blockchain mobile ad campaign »

Kiip and AB Inbev…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GSKY

GreenSky

$24.15

-0.12 (-0.49%)

14:36
06/18/18
06/18
14:36
06/18/18
14:36
Initiation
GreenSky initiated  »

GreenSky initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$83.05

-0.805 (-0.96%)

14:34
06/18/18
06/18
14:34
06/18/18
14:34
Hot Stocks
SOLUTIONS 30, DXC sign strategic partnership in Italy »

SOLUTIONS 30 Italia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QD

Qudian

$9.50

0.01 (0.11%)

14:25
06/18/18
06/18
14:25
06/18/18
14:25
Options
Qudian Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
06/18/18
06/18
14:25
06/18/18
14:25
General news
More from Bostic: a possible yield curve inversion »

More from Bostic: a…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
06/18/18
06/18
14:17
06/18/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.